Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
Condition(s):Psoriatic ArthritisLast Updated:September 11, 2013Unknown status
Hide Studies Not Open or Pending
Condition(s):Psoriatic ArthritisLast Updated:September 11, 2013Unknown status
Condition(s):Dermatomyositis; Juvenile DermatomyositisLast Updated:September 16, 2021Completed
Condition(s):Rheumatoid ArthritisLast Updated:March 17, 2017Unknown status
Condition(s):Uveitis, Posterior; Vasculitis RetinalLast Updated:September 12, 2019Unknown status
Condition(s):Dry Eye DiseaseLast Updated:January 28, 2021Completed
Condition(s):Uveitis; Anterior Uveitis; Intermediate Uveitis; Posterior Uveitis; Scleritis; Clinically Significant Macular EdemaLast Updated:July 2, 2018Completed
Condition(s):Chronic MigraineLast Updated:July 26, 2018Completed
Condition(s):Lupus Erythematosus Systemic ExacerbationLast Updated:July 23, 2013Completed
Condition(s):CNS SarcoidosisLast Updated:April 9, 2021Completed
Condition(s):Multiple SclerosisLast Updated:January 22, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.